Kathleen J. Helton

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 496 citations · Full text

Pediatric Hematology, Hematology, Neurological Monitoring +10

Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit.

R. Grant Steen, Mark A. Miles, Kathleen J. Helton et al. · PubMed · 2003 · 144 citations · Full text

Brain Imaging Findings in Pediatric Patients with Sickle Cell Disease

R. Grant Steen, Temitope Emudianughe, Gisele M. Hankins et al. · Radiology · 2003 · 140 citations

Influence of tumor grade on time to progression after irradiation for localized ependymoma in children

Thomas E. Merchant, Jesse J. Jenkins, Peter C. Burger et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 109 citations

Radiation Medicine, Surgical Oncology, Radiation Therapy +10

Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea

Jane S. Hankins, Kathleen J. Helton, M. Beth McCarville et al. · Pediatric Blood & Cancer · 2007 · 97 citations · Full text